FDA Warning Letter — BioMylz Pvt. Ltd.
The FDA took a Warning Letter action against BioMylz Pvt. Ltd. on July 13, 2026 (Bengaluru, India). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- BioMylz Pvt. Ltd.
- Date
- July 13, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Bengaluru (India)